companydata.dkFamilien Andresens selskab til fremme af medicinsk forskning A/S: Financial statements 2024
CVR: 39694395
Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR 39694395) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -9,518,750 and a net result of DKK -6,685,198 compared with DKK -4,931,284 the year before. Equity amounted to DKK 19,467,195. The solvency ratio was 99.9%. The company had 1 employee in the financial year.
- Gross Profit
- -9,518,750 kr.
- Profit/Loss
- -6,685,198 kr.
- Equity
- 19,467,195 kr.
- Total Assets
- 19,492,195 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9.5 mio. | -6.7 mio. | 19.5 mio. | 1 |
| 2023 | - | -7.5 mio. | -4.9 mio. | 26.2 mio. | 1 |
| 2022 | - | -7.5 mio. | -4.8 mio. | 31.1 mio. | 0 |
| 2021 | - | -7.5 mio. | -4.6 mio. | 35.9 mio. | 0 |
| 2020 | - | -5.5 mio. | -3 mio. | 40.5 mio. | 0 |
How creditworthy is Familien Andresens selskab til fremme af medicinsk forskning A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Familien Andresens selskab til fremme af medicinsk forskning A/S has published its annual report for 2023. Gross profit came to DKK -7,512,250, and the net result was DKK -4,931,284.
About Familien Andresens selskab til fremme af medicinsk forskning A/S
Familien Andresens selskab til fremme af medicinsk forskning A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 2018. The company is registered under the industry Investering for egen regning. The management consists of Jørgen Jacobsen. The company is owned by CALLIE INVEST A/S. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296.